Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuya Asanomi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|August 6, 2010
Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptideJulian Nomme, Axelle Renodon-Cornière, Yuya Asanomi, et al.
Molecular Medicine (Cambridge, Mass.)|June 21, 2019
A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's diseaseYuya Asanomi, Daichi Shigemizu, Akinori Miyashita, et al.
BMC Medical Genomics|November 1, 2019
A comparison of machine learning classifiers for dementia with Lewy bodies using miRNA expression dataDaichi Shigemizu, Shintaro Akiyama, Yuya Asanomi, et al.
Alzheimer Disease and Associated Disorders|July 15, 2022
Early-onset Alzheimer Disease Associated With Neuromyelitis Optica Spectrum DisorderChisato Fujisawa, Naoki Saji, Akinori Takeda, et al.
Translational Psychiatry|March 3, 2021
Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease riskDaichi Shigemizu, Risa Mitsumori, Shintaro Akiyama, et al.
Communications Biology|March 2, 2019
Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression dataDaichi Shigemizu, Shintaro Akiyama, Yuya Asanomi, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|August 6, 2010
Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptideJulian Nomme, Axelle Renodon-Cornière, Yuya Asanomi, et al.
Molecular Medicine (Cambridge, Mass.)|June 21, 2019
A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's diseaseYuya Asanomi, Daichi Shigemizu, Akinori Miyashita, et al.
BMC Medical Genomics|November 1, 2019
A comparison of machine learning classifiers for dementia with Lewy bodies using miRNA expression dataDaichi Shigemizu, Shintaro Akiyama, Yuya Asanomi, et al.
Alzheimer Disease and Associated Disorders|July 15, 2022
Early-onset Alzheimer Disease Associated With Neuromyelitis Optica Spectrum DisorderChisato Fujisawa, Naoki Saji, Akinori Takeda, et al.
Translational Psychiatry|March 3, 2021
Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease riskDaichi Shigemizu, Risa Mitsumori, Shintaro Akiyama, et al.
Communications Biology|March 2, 2019
Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression dataDaichi Shigemizu, Shintaro Akiyama, Yuya Asanomi, et al.
Pageof 2